Today, the U.S. Food and Drug Administration approved Librela (bedinvetmab injection) for the control of pain associated with osteoarthritis (OA) in dogs. Librela is the first monoclonal antibody (mAb) the FDA has approved for use in dogs.
Go to full article: https://www.myvetcandy.com/clinicalupdblog/2023/5/5/first-monoclonal-antibody-for-dogs-with-osteoarthritis-pain-approved-by-fda